Cargando…
Specificity of the T Cell Response to Protein Biopharmaceuticals
The anti-drug antibody (ADA) response is an undesired humoral response raised against protein biopharmaceuticals (BPs) which can dramatically disturb their therapeutic properties. One particularity of the ADA response resides in the nature of the immunogens, which are usually human(ized) proteins an...
Autores principales: | Meunier, Sylvain, de Bourayne, Marie, Hamze, Moustafa, Azam, Aurélien, Correia, Evelyne, Menier, Catherine, Maillère, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387651/ https://www.ncbi.nlm.nih.gov/pubmed/32793213 http://dx.doi.org/10.3389/fimmu.2020.01550 |
Ejemplares similares
-
Pegylation Reduces the Uptake of Certolizumab Pegol by Dendritic Cells and Epitope Presentation to T-Cells
por: de Bourayne, Marie, et al.
Publicado: (2022) -
Introduction of Non-natural Amino Acids Into T-Cell Epitopes to Mitigate Peptide-Specific T-Cell Responses
por: Azam, Aurélien, et al.
Publicado: (2021) -
Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors
por: Hamze, Moustafa, et al.
Publicado: (2017) -
Characterization and Monitoring of Antigen-Responsive T Cell Clones Using T Cell Receptor Gene Expression Analysis
por: Pollastro, Sabrina, et al.
Publicado: (2021) -
Combining deep mutational scanning to heatmap of HLA class II binding of immunogenic sequences to preserve functionality and mitigate predicted immunogenicity
por: Sivelle, Coline, et al.
Publicado: (2023)